JPRN-UMIN000008469招募中未知
Effects of beraprost sodium sustained-release tablet on improvement of insulin resistance in patients with type 2 diabetes with obesity in a Double-Blinded, Randomized, Placebo-Controlled, Crossover Trial. - Effects of beraprost sodium sustained-release tablet on improvement of insulin resistance in patients with type 2 diabetes with obesity.
Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases0 个研究点目标入组 40 人开始时间: 2012年7月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with bleeding tendency Patients with Type 1 diabetes or secondary diabetes Patients with severe renal dysfunction Patients with liver dysfunction Patients with a past history if drug hypersensitivity Pregnant women or women with breast-feeding Patients who took prostaglandin derivatives within 3 months Patients whose prescription drugs were changed within 3 months All Patients who is unsuitable for this trial at a physician's discretion
研究者
相似试验
招募中
不适用
The study of effects of additional beraprost on the amelioration and retention of retinal and choroidal circulation after ranibizumab treatment in age-related macular degeneration.age-related macular degenerationJPRN-UMIN000006869agasaki university40
已完成
不适用
The effect of beraprost sodium on the surrogate markers of atherosclerosis in type 2 diabetes mellitusType 2 Diabetes MellitusJPRN-UMIN000011137Department of Metabolic Medicine Osaka University Graduate School of Medicine25
已完成
不适用
Effects of beraprost sodium on improvement of insulin resistance in patients with type 2 diabetes and peripheral arterial diseasePatients with type 2 diabetes and peripheral arterial diseaseJPRN-UMIN000003089Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases20
已完成
2 期
Efficacy and Safty of Long Acting Beraprost (TRK-100STP) for Lumbar Spinal Canal Stenosis with Intermittent Claudication :A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialJPRN-UMIN000001807KAKEN PHARMACEUTICAL CO., LTD.150
已完成
2 期
Efficacy and Safty of Long Acting Beraprost (TRK-100STP) for Lumbar Spinal Canal Stenosis with Intermittent Claudication :A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcquired degenerative lumbar spinal canal stenosisJPRN-UMIN000005575KAKEN PHARMACEUTICAL CO., LTD150
